| Effect of HPV Integration on Prognosis of Young Women With CIN2 in China (NCT05282095) | Fujian Maternity and Child Health Hospital | 2022-06-01 |
| Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment (NCT05405270) | Catharina Ziekenhuis Eindhoven | 2022-06-01 |
| Cervical Cancer Screening Strategies (NCT05309122) | Lei Li | 2022-03-19 |
| DNA PAX1 and JAM3 Methylation for Cervical Cancer Screening (NCT05290428) | Peking Union Medical College Hospital | 2022-03-12 |
| The Organ Transplant Recipient HPV and Skin Cancer Study (NCT05284877) | Merete Haedersdal | 2022-03-10 |
| Low-cost Imaging Technology for Global Prevention of Cervical Cancer (NCT05078528) | Barretos Cancer Hospital | 2021-09-20 |
| The Dynamic Process of VMB and Mucosal Immunity After FUS Treatment of CIN Patients With Fertility Requirement (NCT05142397) | Shufang Chang | 2021-08-15 |
| Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia (NCT04712851) | Jonsson Comprehensive Cancer Center | 2021-06-30 |
| The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female (NCT05045755) | Jun Zhang | 2021-04-13 |
| The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female (NCT04969445) | Jun Zhang | 2021-03-30 |
| Conservative Management of HSIL in Patients With Future Pregnancy Aspiration (NCT04783805) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2021-03-03 |
| Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (54m) (NCT04704908) | Jun Zhang | 2021-02-06 |
| Immunohistochemical Staining of p16 for the Screening of Cervical Cancer (NCT04650711) | Lei Li | 2020-11-26 |
| HPV-based Screening Among Women 23-29 Years of Age (NCT05229679) | Karolinska Institutet | 2020-11-16 |
| Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device (NCT03429582) | The Cleveland Clinic | 2020-10-30 |
| Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) (NCT04537156) | Xiamen University | 2020-09-05 |
| CASUS: Validation for Detection of Precursor Lesions (NCT04530201) | Universiteit Antwerpen | 2020-08-20 |
| E7 TCR T Cell Immunotherapy for High-Grade Cervical Intraepithelial Neoplasia (NCT04411134) | National Cancer Institute (NCI) | 2020-05-28 |
| Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies (NCT04266093) | National Cancer Institute (NCI) | 2020-05-08 |
| Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female (NCT05426148) | Xiamen Innovax Biotech Co., Ltd | 2020-05-01 |
| Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia (NCT06611020) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2020-01-01 |
| CASUS: Improved and Quality Assured Collection of First-void Urine (NCT04480866) | Universiteit Antwerpen | 2019-07-30 |
| Safety and Efficacy of Laser Therapy in Gynaecology (NCT04073082) | Juna d.o.o. | 2019-07-24 |
| DC Vaccines Targeting HPV16/18 E6/E7 Protein to Regress CINI/CIN2 (NCT03870113) | Shenzhen People's Hospital | 2019-04-01 |
| A Efficacy and Safety Study of Composite Gel Containing Black Raspberry Extract in Removing HPV From Patients With Cervical Intraepithelial Neoplasia(CIN) After Cervical Conization (NCT03745846) | Tianjin Medical University Cancer Institute and Hospital | 2018-12-01 |
| Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study (NCT03629886) | GlaxoSmithKline | 2018-08-22 |
| Changes in Uterine Artery Resistance Index Following Cervical Conization (NCT07653191) | Adana City Training and Research Hospital | 2018-06-20 |
| A Post Marketing Surveillance (PMS) Study to Monitor the Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Female Chinese Subjects (NCT03438006) | GlaxoSmithKline | 2018-05-31 |
| A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study (NCT03355820) | GlaxoSmithKline | 2018-02-28 |
| Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection (NCT03239223) | Antiva Biosciences | 2018-01-01 |
| TMTP1-ICG Mapping in Colposcopy-directed Biopsy (NCT03321461) | Huazhong University of Science and Technology | 2017-11-01 |
| Study of SOR007 Ointment for Cervical Intraepithelial Neoplasia (CIN) (NCT03143491) | DFB Soria, LLC | 2017-10-01 |
| Physical Cold Atmospheric Plasma for the Treatment of Cervical Intraepithelial Neoplasia (NCT03218436) | University Hospital Tuebingen | 2017-09-01 |
| An Innovative Treatment for Cervical Precancer (UH3) (NCT03084081) | The Cleveland Clinic | 2017-08-01 |
| Longitudinal HPV Pap in CIN and VAIN (NCT05931354) | Chang Gung Memorial Hospital | 2017-07-01 |
| Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (NCT03206255) | Jun Zhang | 2017-07-01 |
| E7 TCR T Cells for Human Papillomavirus-Associated Cancers (NCT02858310) | National Cancer Institute (NCI) | 2017-01-27 |
| FASTER-Tlalpan Study in Mexico: HPV Vaccination Impact on Cervical Cancer Screening Program (NCT03105856) | Instituto Nacional de Salud Publica, Mexico | 2017-01-03 |
| Incidence of Cervical Cancer in HPV-positive Women With Low-grade Cytological Abnormalities (NCT07259616) | Gynaecologisch Oncologisch Centrum Zuid | 2017-01-01 |
| Imiquimod Treatment of High-grade CIN (NCT02917746) | Maastricht University Medical Center | 2016-11-01 |
| Impact of HPV Vaccine On The Prevalence Of HPV In Norway (NCT02934724) | Oslo University Hospital | 2016-11-01 |
| Testing Use of Condoms on Regression of Cervical Intraepithelial Neoplasia (NCT02907333) | University of Copenhagen | 2016-09-01 |
| Participation in Screening for Cervical Cancer: Interest of a Self-sampling Device Provided by the General Practitioner (NCT02749110) | University Hospital, Lille | 2016-08-28 |
| Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3) (NCT02864147) | Yale University | 2016-07-01 |
| Imiquimod Treatment of Residual or Recurrent CIN Lesions: a Study Protocol (NCT02669459) | Erasmus Medical Center | 2016-05-01 |
| An Innovative Treatment for Cervical Pre Cancer (NCT02814448) | The Cleveland Clinic | 2016-02-01 |
| A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (NCT02562508) | Jun Zhang | 2015-12-05 |
| A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions (NCT02481414) | University of Arkansas | 2015-11-30 |
| HPV Integration Testing for Human Papillomavirus-Positive Women (NCT02576262) | Huazhong University of Science and Technology | 2015-09-01 |
| HRME: Screening for Cervical Cancer and Its Precursors in Low-Resource Settings (NCT02494310) | Barretos Cancer Hospital | 2015-09-01 |
| Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Plasmid DNA Therapeutic Vaccine(GX-188E) (NCT02596243) | Genexine, Inc. | 2015-08-01 |
| Effect of Curcumin in Treatment of Squamous Cervical Intraepithelial Neoplasias (CINs) (NCT02554344) | Baylor Research Institute | 2015-06-22 |
| Hemodynamic Stability of Bupivacaine With and Without Adrenaline for Paracervical Block for Cervical Conization (NCT02368054) | Helse Fonna | 2015-05-01 |
| HPV Integration Testing for Cervical Cancer Screening (NCT02576158) | Huazhong University of Science and Technology | 2015-04-01 |
| Music Listening to Reduce Pain and Anxiety During LEEP (NCT02398916) | Chiang Mai University | 2015-02-01 |
| Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix (NCT02130323) | United States Naval Medical Center, San Diego | 2015-02-01 |
| Compass - Randomised Controlled Trial of Primary HPV Testing for Cervical Screening in Australia (NCT02328872) | VCS Foundation | 2015-01-01 |
| The Efficacy of Tachosil® for Prevention of Hemorrhage After Loop Electrosurgical Excisional Procedure (LEEP) (NCT02629510) | Asan Medical Center | 2015-01-01 |
| Aminolaevulinic Acid Photodynamic Therapy of Cervical Persistent HPV Infection and Cervical Neoplasia (NCT02304770) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2015-01-01 |
| Imiquimod Treatment of CIN Lesions (NCT02329171) | Maastricht University Medical Center | 2014-12-01 |
| Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer (NCT02140021) | M.D. Anderson Cancer Center | 2014-10-27 |
| Comparing Two Techniques of Haemostasis After Cervical Conization (NCT03293628) | Barretos Cancer Hospital | 2014-10-01 |
| Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia (NCT02139267) | Genexine, Inc. | 2014-07-01 |
| Efficacy and Safety Study of BLS_ILB_E710c for the Fertile Women With Cervical Intraepithelial Neoplasia(CIN3) (NCT02195089) | BioLeaders Corporation | 2014-03-01 |
| DNA Methylation Biomarkers for Cervical Cancer Screening (NCT02605941) | iStat Biomedical CO., Ltd. | 2014-02-01 |
| Phase I, Open-Label Study of the Safety, Tolerability, and Immunogenicity PEK Fusion Protein Vaccine (NCT01880411) | HealthBanks Biotech Co., Ltd. | 2013-06-01 |
| Efficacy and Safety Study of PGA (Poly-gamma Glutamic Acid) for Cervical Intraepithelial Neoplasia (NCT01826045) | BioLeaders Corporation | 2013-06-01 |
| Topical Imiquimod Versus Conization to Treat Cervical Intraepithelial Neoplasia (NCT01283763) | Medical University of Vienna | 2013-05-01 |
| HPV Genotyping by DR. HPV Genotyping in Vitro Diagnostic Device (IVD) Kit in Exfoliated Cells of the Uterine Cervix (NCT04333212) | Chang Gung Memorial Hospital | 2012-12-12 |
| Improving Cervical Cancer Screening Among HIV-Infected Women in India (NCT02247999) | National Cancer Institute (NCI) | 2012-11-28 |
| Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent（Type 16/18 ）Vaccine (NCT01735006) | Xiamen University | 2012-11-22 |
| Study of the Diagnostic Efficacy of "Real Time" Niris 1300e Optical Coherence Tomography (OCT) Imaging System in the Management of Pre-invasive and Invasive Neoplasia of the Uterine Cervix (NCT01766284) | Preventive Oncology International, Inc. | 2012-11-01 |
| Evaluation of Human Papilloma Virus (HPV) Self-testing to Increase Screening Uptake (NCT02095561) | Instituto Nacional del Cáncer, Argentina | 2012-07-01 |
| V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110) (NCT01544478) | Merck Sharp & Dohme LLC | 2011-11-25 |
| Chinese Cancer Prevention Study(CHICAPS) (NCT01524003) | Preventive Oncology International, Inc. | 2011-11-01 |
| Prevaccination Study of Cervical Human Papillomavirus Types in Yangtze River Delta Area, China (NCT01487681) | Xing Xie, MD | 2011-11-01 |
| Visual Inspection With Acetic Acid Compared to Lugol's Iodine in HIV-infected Women (NCT02237326) | University of California, San Francisco | 2011-10-01 |
| Cryotherapy vs. LEEP to Treat Cervical Intraepithelial Neoplasia (CIN) 2/3 Among HIV-positive Women (NCT01298596) | University of Washington | 2011-06-01 |
| The Development of a "Mother/Child, Screen, Treat and Vaccinate Program" in Manchay and Iquitos, Peru (NCT01338051) | Preventive Oncology International, Inc. | 2011-05-01 |
| Dose-finding Study of Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) to Treat Cervical Neoplasia (NCT01256424) | Photocure | 2011-04-01 |
| A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3 (NCT01304524) | Inovio Pharmaceuticals | 2011-04-01 |
| Clinical Evaluation of Polarized Light Assisted Colposcopy (NCT01349621) | Augusta University | 2011-04-01 |
| Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine (NCT01356823) | Xiamen University | 2011-03-01 |
| HPV-cytology Testing Versus Cytology Testing for the Detection of High Grade CIN (NCT01058460) | The University of Hong Kong | 2010-06-01 |
| An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+ (NCT01116245) | Advaxis, Inc. | 2010-04-01 |
| Randomized Trial of Vaginal Self Sampling for Human Papillomavirus (HPV) (NCT01095198) | McMaster University | 2010-04-01 |
| Validation of Implementation of Cervical Dysplasia Treatment Modalities in HIV-Seropositive Women (NCT01723956) | University of Witwatersrand, South Africa | 2010-03-01 |
| Trial to Evaluate Single- and Double- Freeze Cryotherapy in the Prevention of Cervical Neoplasia (NCT01145781) | Tata Memorial Hospital | 2010-01-01 |
| A Comparison Study of Two Community Outreach-Based Approaches to Increase Participation of Women Living in the Mississippi Delta in Cervical Cancer Screening (NCT01058148) | National Cancer Institute (NCI) | 2009-12-22 |
| Randomized Controlled Trial to Study Interventions to Increase Participation in Cervical Cancer Screening Program (NCT01029990) | Göteborg University | 2009-09-01 |
| A Study of RO5217790 in Participants With High Grade Cervical Intraepithelial Neoplasia (CIN) Associated With High Risk Human Papillomavirus (HR-HPV) Infection (NCT01022346) | Hoffmann-La Roche | 2009-08-01 |
| Human Papillomavirus Epidemiology in Nigeria (NCT00804466) | National Cancer Institute (NCI) | 2009-07-06 |
| ITIC (Imiquimod Therapy in Cervical Intraepithelial Neoplasia)-Trial (NCT00941252) | Medical University of Vienna | 2009-07-01 |
| Indirect Comparison Topotecan Cervical Carcinoma (NCT01345279) | GlaxoSmithKline | 2009-06-01 |
| Meta-analysis of Efficacy of Topotecan (NCT01160185) | GlaxoSmithKline | 2009-06-01 |
| Cold Knife Conization With and Without Lateral Hemostatic Sutures (NCT02184975) | Barretos Cancer Hospital | 2009-03-01 |
| Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1 (NCT00708942) | Photocure | 2009-01-01 |
| Evaluation of Initial High Risk Human Papillomavirus (HR-HPV) Viral Load as Predictive Marker for Cervical Intraepithelial Neoplasia Grade 1 (CIN1) Persistence (NCT00682552) | Assistance Publique Hopitaux De Marseille | 2008-05-01 |
| Randomized Clinical Trial on Clinical Management of ASCUS and LSIL (ALTS) (NCT01131312) | National Cancer Institute (NCI) | 2008-02-20 |
| Quality of Life in Thai Women Diagnosed Cervical Cancer at King Chulalongkorn Memorial Hospital (NCT00741533) | Chulalongkorn University | 2008-02-01 |